What is a kidney stone?
A kidney stone is a hard, crystalline mineral material formed within the kidney or urinary tract. Kidney stones are a common cause of blood in the urine and often severe pain in the abdomen, flank, or groin. Kidney stones are sometimes called renal calculi. One in ...
Lung Cancer and EGFR
Overview
A substantial percentage of lung cancers express cell surface epidermal growth factor receptors (EGFRs). As activation of these cell surface receptors has been shown in experimental systems to result in the growth and progression of the malignancy, there have been considerable pre-clinical and clinical research efforts ...
Colorectal Cancer and KRAS
Overview
One actively investigated approach in the management of advanced and metastatic colorectal cancer (CRC) has been the delivery of agents whose primary purpose is to interfere with the biological activity of the epidermal growth factor receptor (EGFR).
However, it is well-recognized that only a subset of patients ...
Chronic Myeloid Leukemia and BCR-ABL
Overview
Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is one of the few cancers that is known to caused by a single, specific genetic mutation in more than 90% of cases.
The transformation to CML is caused by a reciprocal translocation of the BCR ...
Breast Cancer and HER2
Overview
Approximately 30% of malignant breast cancers demonstrate overamplification of the human epidermal receptor type 2 (HER2) gene, resulting in an overexpression of the HER2 receptor, a transmembrane tyrosine kinase receptor within the epidermal growth factor receptor (EGFR) family. Activation of this class of cellular receptors is ...
Jim Maher, Ph.D. Mark McNiven, Ph.D. Dev Mukhopadhyay, Ph.D. __________________________________________________________________ Jim Maher, Ph.D. Vice Chair, Department of Biochemistry and Molecular Biology, Mayo Clinic, Minnesota Article of 90 scientific articles To schedule an interview, call: Media Relations Consultant Bob Nellis (507-284-5005) ___________________________________________________________________________ Mark McNiven, Ph.D., a specialist in protein and cellular function in cancer cell biology [...]
: skip to main skip to sidebar Enjoying the Ride I have Primary Progressive Multiple Sclerosis and sit in an iBOT wheelchair all day . So why do I lead such a contented life Wednesday , April 14, 2010 A Web Forum on CCSVI and What it Could Mean to People Living With MS There was an interesting CCSVI web forum today , hosted by the National Multiple Sclerosis Society NMSS and the American Academy of Neurology AAN The panel convened at the AAN 2010 Annual Meeting in Toronto . nbsp To view a video of the forum , click . here To read a summarry of the forum , click here The panel consisted : of Dr . Paolo Zamboni , Director , Vascular Diseases Center , University of Ferrara , Italy Dr . Robert Zivadinov , Associate Professor of Neurology , University of Buffalo , State University of NY Dr .
Significantly increased levels of multiple sclerosis (MS) disease activity can be seen in MRI scans during the spring and summer months, researchers found.
: , skip to main skip to sidebar BLOG DEDICADO A LAS PERSONAS QUE COMO NOSOTROS , CREEMOS Y SEGUIMOS , LA TEORÍA DEL DOCTOR ZAMBONI En el pasado , los tratamientos no farmacológicos para la Esclerosis Múltiple han sido marginados principalmente por razones financieras . Traductor lunes 30 de agosto de 2010 Y EN ESPAÑA , QUÉ 2 Autor de la viñeta : EL ROTO . Fuente : Diario EL PAÍS . Publicado por Pepe España 07:04 0 comentarios : Publicar un comentario en la entrada Entradas antiguas Página principal Suscribirse a : Enviar comentarios Atom Blog en apoyo a la teoría del Doctor Zamboni Este blog ha sido creado en apoyo a la teoría que están intentando demostrar , si es que los dejan , claro , el Doctor Zamboni y su equipo , en la cual explican , la relación existente entre la Insuficiencia
Fluorouracil Toxicity and DPYD
Overview
5-Fluorouracil (5FU) is a fluorinated pyrimidine analogue commonly used in combination chemotherapy regimens for patients with breast, colorectal, lung, and other malignancies. Dihydropyrimidine dehydrogenase (DPD), an enzyme encoded by the DPYD gene, is the rate-limiting step in pyrimidine catabolism and deactivates more than 80% of standard ...
Michael Joyner, M.D. __________________________________________________________________ Michael Joyner, M.D., a specialist in exercise science, specifically with track and field, world records, doping and the older athlete Author of more than 150 scientific articles Media Experience: Interview experience with national print and broadcast media, including CBS, USA Today and The New York Times. Sample Interview: CBN News To [...]